Friday, 16 October 2026European Markets

MERSEN Stock Bullish Momentum With A 10.59% Rise Before The Weekend

Loading stream...

(vianews) - the market ended the session with mersen (mrn.pa) jumping 10.59% to €33.95 on friday while cac 40 rose 2.28% to €7,634.14.

mersen's last close was €30.70, 33.19% under its 52-week high of €45.95.

about mersen

mersen s.a. manufactures and sells electrical power products and advanced materials in france, north america, rest of europe, the asia-pacific, and internationally. it operates through two segments, advanced materials and electrical power. the company offers electrical protection and control products, such as iec and ul/csa low voltage general purpose fuses and fuse gears, high and medium voltage fuses, and power transfer solutions for rail vehicles, as well as surge protection, lightning protection, and power monitoring solutions; and power management solutions, including high speed fuses, dc protection for electric vehicles and battery, cooling solutions, bus bars, and aluminum electrolytic and film capacitors, as well as industrial motor maintenance and services. it also provides anticorrosion equipment comprising heat exchangers; columns, reactors, and pressure vessels; ptfe / pfa bellows, pipes, elbows, and fittings, as well as other equipment; graphite bursting discs; and corrosion resistant materials, as well as graphite specialties, such as isostatic graphite, carbon insulation, carbon/carbon composites, silicon carbide, and flexible graphite. in addition, the company offers carbon brushes, brush-holders, brush-rockers and brush gear housings, signal and power transmission systems, current collectors, wheel flange lubrication solutions, carbon dust collection systems, monitoring solutions, and slip and electrical ring assemblies, as well as cranes. it serves energy, electronics, transportation, corrosive chemicals, and process industries, as well as other markets comprising building and construction, elevators, elevators, defense, and outdoor led lighting, as well as heating, ventilation, and air conditioning markets. the company was formerly known as groupe carbone lorraine sa and changed its name to mersen s.a. in 2010. mersen s.a. was founded in 1889 and is headquartered in courbevoie, france.

earnings per share

as for profitability, mersen has a trailing twelve months eps of €3.4.

pe ratio

mersen has a trailing twelve months price to earnings ratio of 9.99. meaning, the purchaser of the share is investing €9.99 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.21%.

yearly top and bottom value

mersen's stock is valued at €33.95 at 21:32 est, way below its 52-week high of €45.95 and way above its 52-week low of €29.85.

revenue growth

year-on-year quarterly revenue growth grew by 15.9%, now sitting on 1.2b for the twelve trailing months.

more news about mersen (mrn.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com